Empery Asset Management's Schedule 13G/A Filing for Outlook Therapeutics

Empery Asset Management, LP, along with Ryan M. Lane and Martin D. Hoe, filed a Schedule 13G/A amendment regarding their ownership of Common Stock in Outlook Therapeutics, Inc. The filing indicates that the Reporting Persons collectively own 4.99% of the outstanding Common Stock, which includes shares issuable upon the exercise of Warrants. The Warrants are subject to a Blocker provision, which limits the Reporting Persons from exercising the Warrants to the extent that they would beneficially own more than 4.99% of the outstanding shares. The filing also provides details on the citizenship and business addresses of the Reporting Persons, as well as their roles in the investment management structure.